C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 229/02 (2006.01) C07C 229/50 (2006.01) C07C 235/38 (2006.01) C07C 235/40 (2006.01) C07C 309/08 (2006.01) C07C 311/02 (2006.01) C07C 323/59 (2006.01) C07D 207/16 (2006.01) C07D 209/20 (2006.01) C07D 307/24 (2006.01) C07D 309/08 (2006.01)
Patent
CA 2384511
A family of substituted chiral allosteric effectors of hemoglobin is useful for delivering more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood.
Une famille d'effecteurs allostériques chiraux substitués d'hémoglobine est utile pour délivrer plus d'oxygène aux tissus hypoxyques et ischémiques par réduction de l'affinité de l'hémoglobine pour l'oxygène dans le sang total.
Abraham Donald J.
Danso-Danquah Richmond
Grella Melissa
Hoffman Stephen J.
Joshi Gajanan S.
Allos Therapeutics Inc
Macrae & Co.
Virginia Commonwealth University
LandOfFree
Substituted chiral allosteric hemoglobin modifiers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted chiral allosteric hemoglobin modifiers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted chiral allosteric hemoglobin modifiers will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1815313